Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Employee Benefit Plans (Tables)

v3.8.0.1
Stock-Based Compensation and Employee Benefit Plans (Tables)
 9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(in thousands)
 
(in thousands)
Cost of net revenue
$
93

 
$
56

 
$
231

 
$
150

Research and development
4,337

 
4,332

 
11,841

 
10,916

Selling, general and administrative
2,965

 
1,876

 
7,911

 
5,409

Restructuring
401

 
—

 
4,915

 
—

 
$
7,796

 
$
6,264

 
$
24,898

 
$
16,475

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
 
Number of Shares
(in thousands)
 
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2016
3,670

 
$
14.67

Granted
1,349

 
27.27

Assumed in acquisition
250

 
31.12

Vested
(1,394
)
 
15.88

Canceled
(375
)
 
20.13

Outstanding at September 30, 2017
3,500

 
19.68

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
 
Nine Months Ended
 
September 30, 2017
Weighted-average grant date fair value per share
$6.20 - $7.46

Risk-free interest rate
0.60 - 1.13

Dividend yield
—
%
Expected life (in years)
0.38 - 0.50

Volatility
29.56 - 49.94

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s stock options activity is as follows:
 
Number of Options
(in thousands)
 
Weighted-Average Exercise Price
 
Weighted-Average Contractual Term (in years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016
3,025

 
$
6.78

 
 
 
 
Assumed in acquisition
1,135

 
17.44

 
 
 
 
Exercised
(761
)
 
9.28

 
 
 
 
Canceled
(196
)
 
18.05

 
 
 
 
Outstanding at September 30, 2017
3,203

 
$
9.28

 
2.82
 
$
46,708

Vested and expected to vest at September 30, 2017
3,180

 
$
9.23

 
2.80
 
$
46,525

Exercisable at September 30, 2017
2,643

 
$
8.03

 
2.33
 
$
41,839